MedPath

clinical trail on the effect of Aakshik (Terminalia bellirica) Sidhu on Hb percentage.

Phase 2
Conditions
Health Condition 1: D508- Other iron deficiency anemias
Registration Number
CTRI/2024/03/064628
Lead Sponsor
Sane Guruji Arogya Kendra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients with Hb gm percentage within the range of 9 to 11 g/dl 2) Patients ae between 20 - 40 years. 3) Irrespective of gender, caste and religion.

Exclusion Criteria

1) patients suffering from Haemorrhagic disorders. 2) Patients suffering from chronic illness like DM, HTN, TB, HIV, Leukemia, liver diseases, endocrinal disorders. 3) Pregnant women, lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the effect of Aakshik Sidhu on Hb percentage with special reference to iron deficiency anemia.Timepoint: 1 year
Secondary Outcome Measures
NameTimeMethod
To prepare and standardize Aakshik Sidhu. <br/ ><br>To study the effect of Aakshik Sidhu on Pandu Roga Lakshanas.Timepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath